Konstantina Chachlaki,Andrea Messina,Virginia Delli,Valerie Leysen,Csilla Maurnyi,Chieko Huber,Gaëtan Ternier,Katalin Skrapits,Georgios Papadakis,Sonal Shruti,Maria Kapanidou,Xu Cheng,James Acierno,Jesse Rademaker,Sowmyalakshmi Rasika,Richard Quinton,Marek Niedziela,Dagmar L'Allemand,Duarte Pignatelli,Mirjam Dirlewander,Mariarosaria Lang-Muritano,Patrick Kempf,Sophie Catteau-Jonard,Philippe Ciofi,Manuel Tena-Sempere,John Garthwaite,Laurent Storme,Paul Avan,Erik Hrabovszky,Alan Carleton,Federico Santoni,Paolo Giacobini,Nelly Pitteloud,Vincent Prevot,Nicolas J. Niederländer

Abstract:The nitric oxide (NO) signaling pathway in hypothalamic neurons plays a key role in the regulation of the secretion of gonadotropin-releasing hormone (GnRH), which is crucial for reproduction. We hypothesized that a disruption of neuronal NO synthase (NOS1) activity underlies some forms of hypogonadotropic hypogonadism. Whole-exome sequencing was performed on a cohort of 341 probands with congenital hypogonadotropic hypogonadism to identify ultrarare variants in NOS1 . The activity of the identified NOS1 mutant proteins was assessed by their ability to promote nitrite and cGMP production in vitro. In addition, physiological and pharmacological characterization was carried out in a Nos1 -deficient mouse model. We identified five heterozygous NOS1 loss-of-function mutations in six probands with congenital hypogonadotropic hypogonadism (2%), who displayed additional phenotypes including anosmia, hearing loss, and intellectual disability. NOS1 was found to be transiently expressed by GnRH neurons in the nose of both humans and mice, and Nos1 deficiency in mice resulted in dose-dependent defects in sexual maturation as well as in olfaction, hearing, and cognition. The pharmacological inhibition of NO production in postnatal mice revealed a critical time window during which Nos1 activity shaped minipuberty and sexual maturation. Inhaled NO treatment at minipuberty rescued both reproductive and behavioral phenotypes in Nos1 -deficient mice. In summary, lack of NOS1 activity led to GnRH deficiency associated with sensory and intellectual comorbidities in humans and mice. NO treatment during minipuberty reversed deficits in sexual maturation, olfaction, and cognition in Nos1 mutant mice, suggesting a potential therapy for humans with NO deficiency.

The IgLON family of cell adhesion molecules expressed in developing neural circuits ensure the proper functioning of the sensory system in mice

Alternative Promoter Use Governs the Expression of IgLON Cell Adhesion Molecules in Histogenetic Fields of the Embryonic Mouse Brain

IgLON5 deficiency produces behavioral alterations in a knockout mouse model

Disruption of Nectin-Like 1 Cell Adhesion Molecule Leads to Delayed Axonal Myelination in the CNS

The Role of IgLON Cell Adhesion Molecules in Neurodegenerative Diseases

MicroRNAs Associated with IgLON Cell Adhesion Molecule Expression

IgLON cell adhesion molecules are shed from the cell surface of cortical neurons to promote neuronal growth

Expression of expanded GGC repeats within NOTCH2NLC causes behavioral deficits and neurodegeneration in a mouse model of neuronal intranuclear inclusion disease

The Risk Genes for Neuropsychiatric Disorders negr1 and opcml Are Expressed throughout Zebrafish Brain Development

Mice Mutated in the First Fibronectin Domain of Adhesion Molecule L1 Show Brain Malformations and Behavioral Abnormalities

Regulation of Hippocampal Long Term Depression by Neuroligin 1.

A Central Role for Islet1 in Sensory Neuron Development Linking Sensory and Spinal Gene Regulatory Programs

A trans-synaptic IgLON adhesion molecular complex directly contacts and clusters a nicotinic receptor

New insights into the expression and function of neural connexins with transgenic mouse mutants

NOS1 mutations cause hypogonadotropic hypogonadism with sensory and cognitive deficits that can be reversed in infantile mice

ISL1 and POU4F1 Directly Interact to Regulate the Differentiation and Survival of Inner Ear Sensory Neurons

ADGRL1 Haploinsufficiency Causes a Variable Spectrum of Neurodevelopmental Disorders in Humans and Alters Synaptic Activity and Behavior in a Mouse Model.

Microglia-Derived Insulin-like Growth Factor 1 Is Critical for Neurodevelopment

Maf and Mafb control mouse pallial interneuron fate and maturation through neuropsychiatric disease gene regulation

A Neurological Phenotype in Nail Patella Syndrome (nps) Patients Illuminated by Studies of Murine Lmx1b Expression

Anti-IgLON5 antibodies cause progressive behavioral and neuropathological changes in mice